Tower Research Capital (TRC)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,633
Closed -$167K 6368
2023
Q2
$167K Buy
1,633
+873
+115% +$89K 0.01% 1675
2023
Q1
$69K Buy
760
+327
+76% +$29.7K ﹤0.01% 2218
2022
Q4
$16K Sell
433
-2,448
-85% -$90.5K ﹤0.01% 3392
2022
Q3
$72K Buy
2,881
+1,840
+177% +$46K ﹤0.01% 2855
2022
Q2
$32K Sell
1,041
-8,635
-89% -$265K ﹤0.01% 3317
2022
Q1
$317K Buy
9,676
+7,283
+304% +$239K ﹤0.01% 1444
2021
Q4
$63K Buy
2,393
+1,974
+471% +$52K ﹤0.01% 2586
2021
Q3
$42K Sell
419
-892
-68% -$89.4K ﹤0.01% 3103
2021
Q2
$185K Buy
1,311
+749
+133% +$106K ﹤0.01% 1987
2021
Q1
$56K Buy
562
+13
+2% +$1.3K ﹤0.01% 3038
2020
Q4
$68K Sell
549
-572
-51% -$70.8K ﹤0.01% 2770
2020
Q3
$109K Sell
1,121
-2,815
-72% -$274K ﹤0.01% 3094
2020
Q2
$614K Buy
3,936
+1,319
+50% +$206K 0.03% 840
2020
Q1
$378K Buy
+2,617
New +$378K 0.02% 529
2019
Q4
Sell
-545
Closed -$44K 4605
2019
Q3
$44K Buy
545
+513
+1,603% +$41.4K ﹤0.01% 1900
2019
Q2
$3K Buy
+32
New +$3K ﹤0.01% 3186
2019
Q1
Sell
-102
Closed -$6K 4453
2018
Q4
$6K Sell
102
-1,296
-93% -$76.2K ﹤0.01% 2833
2018
Q3
$114K Buy
1,398
+1,027
+277% +$83.7K 0.01% 1272
2018
Q2
$13K Buy
+371
New +$13K ﹤0.01% 2679
2018
Q1
Sell
-2,771
Closed -$78K 4062
2017
Q4
$78K Buy
2,771
+1,440
+108% +$40.5K 0.01% 1029
2017
Q3
$41K Buy
+1,331
New +$41K ﹤0.01% 2158
2017
Q2
Sell
-155
Closed -$4K 3743
2017
Q1
$4K Sell
155
-407
-72% -$10.5K ﹤0.01% 2374
2016
Q4
$12K Buy
562
+462
+462% +$9.87K ﹤0.01% 2555
2016
Q3
$3K Sell
100
-332
-77% -$9.96K ﹤0.01% 2930
2016
Q2
$8K Buy
+432
New +$8K ﹤0.01% 3055